{"database": "lobbying", "table": "lobbying_activities", "rows": [[1693950, "53c42e80-b24c-4e6d-b737-70b8b1306145", "Q2", "GARY BUEHLER", 401103724, "TEVA PHARMACEUTICALS USA, INC.", 2015, "second_quarter", "PHA", "Section 505(b)(2) new drug applications and exclusivity period.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2015-07-13T16:52:07.160000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1693950"], "units": {}, "query_ms": 2.3626010515727103, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}